Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Xortx Therapeutics Inc (XRTX)

Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
XORTX Strengthens Executive Team GlobeNewswire - Thu Dec 19, 6:00AM CST

XRTX.VN : 1.570 (-2.48%)
XRTX : 1.0900 (-2.68%)
XORTX Announces Presentation at the Rare and Genetic Disease Summit GlobeNewswire - Thu Dec 12, 8:17AM CST

XRTX.VN : 1.570 (-2.48%)
XRTX : 1.0900 (-2.68%)
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024 GlobeNewswire - Thu Oct 24, 6:00AM CDT

XRTX.VN : 1.570 (-2.48%)
XRTX : 1.0900 (-2.68%)
XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement GlobeNewswire - Fri Oct 18, 3:00PM CDT

XRTX.VN : 1.570 (-2.48%)
XRTX : 1.0900 (-2.68%)
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement GlobeNewswire - Thu Oct 17, 7:00AM CDT

XRTX.VN : 1.570 (-2.48%)
XRTX : 1.0900 (-2.68%)
XORTX Initiates Precision Medicine Program GlobeNewswire - Wed Oct 9, 4:00AM CDT

XRTX.VN : 1.570 (-2.48%)
XRTX : 1.0900 (-2.68%)
XORTX Announces Submission to European Medicines Agency Globe Newswire - Tue Jul 19, 2022

Scientific Advice from EMA Committee for Medicinal Products for Human Use Requested...

XRTX.VN : 1.570 (-2.48%)
XRTX : 1.0900 (-2.68%)
XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical Trial Globe Newswire - Wed Jul 13, 2022

Clinical Trial Shows Substantially Improved Bioavailiability...

XRTX.VN : 1.570 (-2.48%)
XRTX : 1.0900 (-2.68%)
XORTX Announces Pre-Phase 3 Meeting Request with US Food and Drug Administration (FDA) Globe Newswire - Thu Jul 7, 2022

CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

XRTX.VN : 1.570 (-2.48%)
XRTX : 1.0900 (-2.68%)
XORTX to Present at BIO International Convention 2022 Globe Newswire - Mon Jun 13, 2022

CALGARY, Alberta, June 13, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

XRTX.VN : 1.570 (-2.48%)
XRTX : 1.0900 (-2.68%)

Barchart Exclusives

Is It Time to Sell This Second-Fiddle AI Stock Before 2025? Barchart - 43 minutes ago
Bank of America has cut its rating on AMD while lowering its price target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot